High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren’s syndrome
Abstract In present study, we aimed to study salivary soluble L-selectin (sL-selectin), interleukin-7(IjL-7), and lymphotoxin-α levels in primary Sjögren’s syndrome (pSS) and their clinical as well as serological correlations. pSS patients fulfilling either the American European Consensus Group (AECG) and/or the American college of Rheumatology (ACR) criteria were recruited. Age- and sex-matched hospital staff were recruited as healthy controls. Unstimulated saliva was collected by the spitting method; sL-selectin, IL-7, and lymphotoxin-α were measured in the saliva using commercial ELISA kits. Forty-three patients with pSS and 31 healthy controls were included in the study. Increased levels of sL-selectin and IL-7 were found in the saliva of patients as compared to controls. Lymphotoxin-α was undetectable in the saliva of pSS patients and controls. Salivary sL-selectin positively correlated with rheumatoid factor (r = 0.47; p < 0.003). No other variable including ESSDAI was significantly associated with salivary sL-selectin and IL-7 levels. Indian patients with primary Sjögren’s syndrome have higher salivary sL-selectin and IL-7 levels than healthy controls..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Clinical rheumatology - 35(2016), 12 vom: 12. Sept., Seite 3063-3067 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kabeerdoss, Jayakanthan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Interleukin-7 |
| doi: |
10.1007/s10067-016-3406-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR008519714 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR008519714 | ||
| 003 | DE-627 | ||
| 005 | 20230519214752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201005s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10067-016-3406-7 |2 doi | |
| 035 | |a (DE-627)SPR008519714 | ||
| 035 | |a (SPR)s10067-016-3406-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.00 |2 bkl | ||
| 084 | |a 44.83 |2 bkl | ||
| 100 | 1 | |a Kabeerdoss, Jayakanthan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren’s syndrome |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract In present study, we aimed to study salivary soluble L-selectin (sL-selectin), interleukin-7(IjL-7), and lymphotoxin-α levels in primary Sjögren’s syndrome (pSS) and their clinical as well as serological correlations. pSS patients fulfilling either the American European Consensus Group (AECG) and/or the American college of Rheumatology (ACR) criteria were recruited. Age- and sex-matched hospital staff were recruited as healthy controls. Unstimulated saliva was collected by the spitting method; sL-selectin, IL-7, and lymphotoxin-α were measured in the saliva using commercial ELISA kits. Forty-three patients with pSS and 31 healthy controls were included in the study. Increased levels of sL-selectin and IL-7 were found in the saliva of patients as compared to controls. Lymphotoxin-α was undetectable in the saliva of pSS patients and controls. Salivary sL-selectin positively correlated with rheumatoid factor (r = 0.47; p < 0.003). No other variable including ESSDAI was significantly associated with salivary sL-selectin and IL-7 levels. Indian patients with primary Sjögren’s syndrome have higher salivary sL-selectin and IL-7 levels than healthy controls. | ||
| 650 | 4 | |a Interleukin-7 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lymphotoxin-α |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Saliva |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sjögren’s syndrome |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Soluble L-selectin |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Sandhya, Pulukool |e verfasserin |4 aut | |
| 700 | 1 | |a Mandal, Santosh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Gowri, Mahasampath |e verfasserin |4 aut | |
| 700 | 1 | |a Danda, Debashish |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical rheumatology |d London : Springer, 1982 |g 35(2016), 12 vom: 12. Sept., Seite 3063-3067 |w (DE-627)SPR008480389 |w (DE-600)1480901-1 |x 1434-9949 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2016 |g number:12 |g day:12 |g month:09 |g pages:3063-3067 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10067-016-3406-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.00 |q ASE |
| 936 | b | k | |a 44.83 |q ASE |
| 951 | |a AR | ||
| 952 | |d 35 |j 2016 |e 12 |b 12 |c 09 |h 3063-3067 | ||